Induction of oxidative stress in antitubercular drug-induced hepatotoxicity.
dc.contributor.author | Chowdhury, A | en_US |
dc.contributor.author | Santra, A | en_US |
dc.contributor.author | Kundu, S | en_US |
dc.contributor.author | Mukherjee, A | en_US |
dc.contributor.author | Pandit, A | en_US |
dc.contributor.author | Chaudhuri, S | en_US |
dc.contributor.author | Dhali, G K | en_US |
dc.date.accessioned | 2001-05-13 | en_US |
dc.date.accessioned | 2009-05-29T03:30:04Z | |
dc.date.available | 2001-05-13 | en_US |
dc.date.available | 2009-05-29T03:30:04Z | |
dc.date.issued | 2001-05-13 | en_US |
dc.description.abstract | BACKGROUND AND AIM: Oxidative stress could play a role in the pathogenesis of antitubercular drug (ATD)-induced hepatotoxicity. We therefore studied the plasma level of reduced glutathione (GSH) and malondialdehyde (MDA) in patients with ATD-induced hepatotoxicity (cases), ATD-treated controls (disease controls) and in healthy volunteers. METHODS: This study was carried out in a case-control design. Twenty-one cases, 21 age- and sex-matched disease controls, and 10 healthy volunteers were enrolled. Plasma levels of GSH and MDA were measured. RESULTS: Plasma levels of GSH (median [range] 11.5 [6.2-21.2] mmol/dL) and MDA (1390 [560-2310] nmol/dL) of cases were significantly different (p<0.01) from GSH (18.4 [10.5-24.4]) and MDA (290 [240-550]) of disease controls. Further, plasma GSH and MDA levels of both the ATD-treated groups were different from those in healthy controls. CONCLUSION: Lower levels of plasma GSH and higher levels of MDA may be due to oxidative stress resulting from ATD therapy. | en_US |
dc.description.affiliation | Department of Gastroenterology, Institute of Post Graduate Medical Education and Research, Kolkata. achowdhury@apexmail.com | en_US |
dc.identifier.citation | Chowdhury A, Santra A, Kundu S, Mukherjee A, Pandit A, Chaudhuri S, Dhali GK. Induction of oxidative stress in antitubercular drug-induced hepatotoxicity. Indian Journal of Gastroenterology. 2001 May-Jun; 20(3): 97-100 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/65412 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.indianjgastro.com | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antitubercular Agents --adverse effects | en_US |
dc.subject.mesh | Case-Control Studies | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Glutathione --blood | en_US |
dc.subject.mesh | Hepatitis, Toxic --blood | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Linear Models | en_US |
dc.subject.mesh | Liver Function Tests | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Malondialdehyde --blood | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Oxidative Stress | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Statistics, Nonparametric | en_US |
dc.subject.mesh | Tuberculosis --drug therapy | en_US |
dc.title | Induction of oxidative stress in antitubercular drug-induced hepatotoxicity. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1